Shares of ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATF – Get Free Report) were up 0.4% during trading on Friday. The stock traded as high as $1.37 and last traded at $1.33. 117,083 shares traded hands during trading, an increase of 476% from the average session volume of 20,327 shares. The stock had previously closed at $1.3250.
ImmunoPrecise Antibodies Price Performance
The business’s 50-day moving average is $1.36 and its 200 day moving average is $1.38.
About ImmunoPrecise Antibodies
ImmunoPrecise Antibodies Ltd. is a biotechnology company that provides antibody discovery and development services to pharmaceutical, biotechnology and research organizations. The company helps clients identify and optimize antibodies for applications including therapeutic development, diagnostics and research.
Its offerings include antibody generation through animal immunization, hybridoma and phage-display technologies, as well as single-cell sequencing, antibody engineering, characterization and production support.
Featured Articles
- Five stocks we like better than ImmunoPrecise Antibodies
- AST SpaceMobile’s BlueBird Progress Comes With Several Risks Still Unresolved
- Time to Nibble on MCD Stock After it Enters Oversold Territory?
- McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal Upside
- Corning and AT&T’s $3 Billion Fiber Deal Reveals Where AI Spending Goes Next
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
